nimble_asset_Website-banner-Assessments

TIMELINE OF ASSESSMENT

The table below shows the Timeline of Other COVID-19 Health Technologies for HTA.

 

HEALTH TECHNOLOGY CASIRIVIMAB+INDEVIMAB DEXAMETHASONE FAVIPIRAVIR REMDESIVIR BARICITINIB TOCILUZIMAB
PROPONENT Disease Prevention and Control Bureau (DPCB) Philippine Academy of Ophthalmology DOH Disease Prevention and Control Bureau DOH Disease Prevention and Control Bureau DOH Disease Prevention and Control Bureau DOH Disease Prevention and Control Bureau
TOPIC NOMINATION
TOPIC PRIORITIZATION
ASSESSMENT
RECOMMENDATION
DECISION OF THE SECRETARY OF HEALTH
DISSEMINATION Link to HTAC RecommendationLink to Signed Endorsement Letter and Evidence SummaryDexamethasoneLink to issuanceDexamethasoneLink to issuanceDexamethasoneLink to issuanceDexamethasoneLink to issuance